Skip to content

Energy Supply in Athletes and Untrained Persons With Bronchopulmonary Diseases

Study of Energy Supply in Athletes and Untrained Persons With Diseases of the Bronchopulmonary System

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04415827
Enrollment
170
Registered
2020-06-04
Start date
2020-05-23
Completion date
2022-12-01
Last updated
2020-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Infection, Bronchitis, Chronic Obstructive Pulmonary Disease, Community-acquired Pneumonia

Keywords

sports medicine, bicycle ergometry, bronchopulmonary diseases, spiroergometry

Brief summary

Study of the energy supply of bicycle ergometric load in athletes and untrained persons with bronchopulmonary diseases (community-acquired pneumonia, bronchitis, chronic obstructive pulmonary disease and acute respiratory viral infections, to justify the timing of the resumption of training, as well as determination of the volume and intensity of physical activity in training and competitive processes.

Detailed description

1. The aim of the study is to assess energy supply of bicycle ergometric load in athletes and untrained persons who have suffered diseases of the bronchopulmonary system (community-acquired pneumonia, bronchitis, chronic obstructive pulmonary disease and acute respiratory viral infections, to justify the timing of the resumption of training, as well as determining the volume and the intensity of physical activity in the training and competitive processes. 2. In addition to a comprehensive general clinical, radiological (for community-acquired pneumonia) and laboratory examination, all the subjects under study will undergo special studies: spirography and spiroergometry, electrocardiography (ECG), and bicycle ergometry. 3. The main indicators of the functional state of the cardio-respiratory system of the study participants are indicators of the function of external respiration and gas exchange, recorded in the initial state, after load and in the recovery period of 10 and 30 minutes. Patients with diseases of the bronchopulmonary system will receive treatment according to generally accepted standards of drug treatment.

Interventions

DIAGNOSTIC_TESTbicycle ergometry test with spiroergometry

The 1st testing will be carried out on the 28-31th day of the disease, which corresponds to the period of the expected normalization of temperature, improvement of well-being, positive dynamics of radiological (with community-acquired pneumonia) and laboratory data, the 2nd test - after 3 months, the 3rd - after 6 months and IV - after 12 months. Load testing will be carried out on a bicycle ergometer with an initial power of 25 watts with a further increase of 25 watts every 3 minutes. The cessation of the load will be carried out upon the appearance of signs set forth in the recommendations of the World Health Organization Expert Committee (1970)

Sponsors

I.M. Sechenov First Moscow State Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
17 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

1. the presence of written informed consent of the patient to participate in the study; 2. athletes (men and women) with a diagnosis of community-acquired pneumonia / bronchitis / chronic obstructive pulmonary disease / acute respiratory viral infection on days 28-31 from the onset of the disease, i.e. in the stage of clinical recovery; 3. untrained individuals (men and women) with a diagnosis of community-acquired pneumonia / bronchitis / chronic obstructive pulmonary disease / acute respiratory viral infection; 4. age 17 - 25 years.

Exclusion criteria

1. refusal of the patient from further participation in the study; 2. non-compliance with treatment recommendations and regimen.

Design outcomes

Primary

MeasureTime frameDescription
Change of the respiratory system function at different periods of the bronchopulmonary diseaseThe 1st test will be carried out on the 28-31th day of the disease, the 2nd test - after 3 months, III - after 6 months and IV - after 12 months.assesment a change of respiratory rate using stress test machine Cardiovit in the initial state, after cycling and in the recovery period for 10 and 30 minutes.
Change of the cardiovascular system function at different periods of the bronchopulmonary diseaseThe 1st test will be carried out on the 28-31th day of the disease, the 2nd test - after 3 months, III - after 6 months and IV - after 12 months.assesment a change of heart rate using stress test machine Cardiovit in the initial state, after cycling and in the recovery period for 10 and 30 minutes.

Secondary

MeasureTime frameDescription
Change of electrical activity of the heart at different periods of the bronchopulmonary diseaseThe 1st test will be carried out on the 28-31th day of the disease, the 2nd test - after 3 months, III - after 6 months and IV - after 12 months.assesment a change of the electrical activity of the heart using stress test machine Cardiovit, recording changes on an ECG (segment ST) during cycling.
Change of pulmonary ventilation at different periods of the bronchopulmonary diseaseThe 1st test will be carried out on the 28-31th day of the disease, the 2nd test - after 3 months, III - after 6 months and IV - after 12 months.assesment a change of the pulmonary ventilation using stress test machine Cardiovit, determining tidal volume (l/min) in the initial state, after cycling and in the recovery period for 10 and 30 minutes.
Change of pulmonary gas exchange at different periods of the bronchopulmonary diseaseThe 1st test will be carried out on the 28-31th day of the disease, the 2nd test - after 3 months, III - after 6 months and IV - after 12 months.assesment a change of oxygen uptake (ml/min) using stress test machine Cardiovit in the initial state, after cycling and in the recovery period for 10 and 30 minutes.

Countries

Russia

Contacts

Primary ContactViktoria S Moskvichyova
moskvicheva_viktoria@mail.ru+79251290922
Backup ContactIrina A Lazareva
ialazareva@mail.ru+79032316255

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026